New bd benchtop cell analyzer enhances laboratory access and accelerates scientific research

Franklin lakes, n.j., aug. 11, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced the launch of a new benchtop cell analyzer that brings sophisticated flow cytometry capabilities to laboratories of all sizes.
BDX Ratings Summary
BDX Quant Ranking